Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$24.87
-0.5%
$15.99
$8.89
$25.30
$1.08BN/A536,164 shs885,344 shs
LivaNova PLC stock logo
LIVN
LivaNova
$56.52
-3.7%
$49.20
$32.48
$58.91
$3.09B0.96700,142 shs468,382 shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.76
-0.3%
$20.49
$14.22
$23.00
$3.45B0.992.50 million shs1.73 million shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$27.09
+0.5%
$24.60
$13.63
$29.73
$2.85B2.12.17 million shs1.52 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
+8.08%+31.44%+69.61%+30.82%+2,499,999,900.00%
LivaNova PLC stock logo
LIVN
LivaNova
+0.69%+3.16%+20.23%+25.74%+24.70%
Envista Holdings Corporation stock logo
NVST
Envista
-1.44%+0.66%+2.79%+8.46%+22.67%
Warby Parker Inc. stock logo
WRBY
Warby Parker
+0.64%+5.12%+15.17%+19.23%+93.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$24.87
-0.5%
$15.99
$8.89
$25.30
$1.08BN/A536,164 shs885,344 shs
LivaNova PLC stock logo
LIVN
LivaNova
$56.52
-3.7%
$49.20
$32.48
$58.91
$3.09B0.96700,142 shs468,382 shs
Envista Holdings Corporation stock logo
NVST
Envista
$20.76
-0.3%
$20.49
$14.22
$23.00
$3.45B0.992.50 million shs1.73 million shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$27.09
+0.5%
$24.60
$13.63
$29.73
$2.85B2.12.17 million shs1.52 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
+8.08%+31.44%+69.61%+30.82%+2,499,999,900.00%
LivaNova PLC stock logo
LIVN
LivaNova
+0.69%+3.16%+20.23%+25.74%+24.70%
Envista Holdings Corporation stock logo
NVST
Envista
-1.44%+0.66%+2.79%+8.46%+22.67%
Warby Parker Inc. stock logo
WRBY
Warby Parker
+0.64%+5.12%+15.17%+19.23%+93.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2.75
Moderate Buy$22.56-8.79% Downside
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.715.32% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.33
Hold$20.920.86% Upside
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.55
Moderate Buy$24.06-10.08% Downside

Current Analyst Ratings Breakdown

Latest BBNX, NVST, LIVN, and WRBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
9/3/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$64.00
8/21/2025
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$55.00 ➝ $58.00
8/8/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/8/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$20.00 ➝ $23.00
8/8/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$21.00 ➝ $22.00
8/7/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingPositive
8/7/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Telsey Advisory Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$28.00
8/7/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$24.00 ➝ $28.00
8/5/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetNeutral$24.00
8/1/2025
Envista Holdings Corporation stock logo
NVST
Envista
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$24.00 ➝ $25.00
(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
$78.02M13.78N/AN/A($5.72) per share-4.32
LivaNova PLC stock logo
LIVN
LivaNova
$1.31B2.36$4.12 per share13.75$24.31 per share2.33
Envista Holdings Corporation stock logo
NVST
Envista
$2.55B1.35$1.63 per share12.73$17.05 per share1.22
Warby Parker Inc. stock logo
WRBY
Warby Parker
$771.32M3.65$0.34 per share78.79$3.35 per share7.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$54.76MN/A0.00N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$63.23M-$3.89N/A18.06N/A-16.13%14.57%6.91%10/29/2025 (Estimated)
Envista Holdings Corporation stock logo
NVST
Envista
-$1.12B$0.3264.7917.141.132.11%4.84%2.68%10/29/2025 (Estimated)
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$20.39M-$0.07N/A267.60N/A-1.12%-0.79%-0.41%11/6/2025 (Estimated)

Latest BBNX, NVST, LIVN, and WRBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
LivaNova PLC stock logo
LIVN
LivaNova
$0.84$1.05+$0.21$0.50$332.20 million$352.50 million
7/31/2025Q2 2025
Envista Holdings Corporation stock logo
NVST
Envista
$0.24$0.26+$0.02$0.16$638.21 million$682.10 million
7/29/2025Q2 2025
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
-$0.51-$0.39+$0.12-$0.39$19.73 million$23.24 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
14.68
13.79
LivaNova PLC stock logo
LIVN
LivaNova
0.31
1.29
1.09
Envista Holdings Corporation stock logo
NVST
Envista
0.46
2.44
2.08
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/A
2.55
2.23

Institutional Ownership

CompanyInstitutional Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Envista Holdings Corporation stock logo
NVST
Envista
N/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
93.24%

Insider Ownership

CompanyInsider Ownership
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
Envista Holdings Corporation stock logo
NVST
Envista
0.66%
Warby Parker Inc. stock logo
WRBY
Warby Parker
18.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
29443.47 millionN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.60 million54.44 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,300166.18 million165.09 millionOptionable
Warby Parker Inc. stock logo
WRBY
Warby Parker
3,780105.19 million86.00 millionOptionable

Recent News About These Companies

Evercore ISI Reaffirms Their Hold Rating on Warby Parker (WRBY)
Warby Parker (NYSE:WRBY) Stock Rating Lowered by Wall Street Zen
Zacks Research Upgrades Warby Parker (NYSE:WRBY) to "Hold"
Warby Parker (NYSE:WRBY) Upgraded at Zacks Research

New MarketBeat Followers Over Time

Media Sentiment Over Time

Beta Bionics stock logo

Beta Bionics NASDAQ:BBNX

$24.87 -0.13 (-0.52%)
As of 04:00 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$56.52 -2.20 (-3.75%)
Closing price 04:00 PM Eastern
Extended Trading
$56.48 -0.04 (-0.07%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Envista stock logo

Envista NYSE:NVST

$20.76 -0.06 (-0.26%)
Closing price 03:59 PM Eastern
Extended Trading
$20.78 +0.02 (+0.10%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Warby Parker stock logo

Warby Parker NYSE:WRBY

$27.09 +0.13 (+0.47%)
Closing price 03:59 PM Eastern
Extended Trading
$26.81 -0.28 (-1.02%)
As of 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.